Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study on Durvalumab with Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on Preoperative Treatment with Amivantamab, Carboplatin, and Pemetrexed for Patients with Resectable Non-Small-Cell Lung Cancer with EGFR Mutations

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Belgium Germany The Netherlands
  • Study of sacituzumab govitecan and zimberelimab treatment before and after surgery for patients with resectable non-small cell lung cancer

    Not yet recruiting

    2 1 1 1
    Germany
  • Carboplatin‑based drug combination for advanced non‑small cell lung cancer patients with interstitial lung disease

    Not yet recruiting

    2 1 1 1
    France
  • A study of PF-08634404 and sigvotatug vedotin in patients with advanced solid tumors

    Not yet recruiting

    1 1 1
    France Germany Italy Spain
  • Study on Pembrolizumab as Maintenance Therapy for Patients with Unresectable Stage III Non-Small Cell Lung Cancer After Chemo-Radiotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    Italy
  • Study on the Safety and Effectiveness of Azacitidine and Pembrolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Platinum Treatment

    Not recruiting

    2 1 1
    Investigated Drugs:
    Italy
  • Study on Thoracic Radiotherapy and Durvalumab for Elderly or Frail Stage III Non-Small Cell Lung Cancer Patients Unable to Undergo Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Germany
  • Study on Durvalumab and Chemotherapy for Patients with Resectable Stage III Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Germany
  • Study on the Safety and Effectiveness of GB1211 and Atezolizumab for Patients with Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    France Spain